IONIS PHARMACEUTICALS INC
IONS
78 insider filings · Latest: Jul 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Sale | 54,878 | $79.35 | $4.4M | 3,811(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 20,106 | $79.40 | $1.6M | 22,541(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Sale | 85,089 | $79.23 | $6.7M | 80,554(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 439 | $80.00 | $35.1K | 4,347(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 6,220 | $79.72 | $495.9K | 4,347(I) | View → |
| Mar 3, 2026 | Mar 3 10:52 PM | BENNETT C FRANK | Proposed Sale | 85,089 | $82.93 | $7.1M | — | View → |
| Mar 3, 2026 | Mar 3 10:51 PM | LOSCALZO JOSEPH | Proposed Sale | 24,000 | $80.00 | $1.9M | — | View → |
| Mar 3, 2026 | Mar 3 10:43 PM | Baroldi Mariana | Proposed Sale | 8,198 | $80.00 | $655.8K | — | View → |
| Mar 3, 2026 | Mar 3 10:42 PM | Baroldi Joseph | Proposed Sale | 4,096 | $79.36 | $325.1K | — | View → |
| Mar 3, 2026 | Mar 3 10:35 PM | KLEIN JOSEPH III | Proposed Sale | 65,345 | $77.07 | $5.0M | — | View → |
| Mar 3, 2026 | Mar 3 10:34 PM | Devers Shannon L. | Proposed Sale | 39,014 | $79.50 | $3.1M | — | View → |
| Feb 13, 2026 | Feb 14 12:40 AM | Eric SwayzeEVP Research | Sale | 15,642 | $81.76 | $1.3M | 32,105(D) | View → |
| Feb 11, 2026 | Feb 14 12:40 AM | Lynne B ParshallDirector | Sale | 5,000 | $82.72 | $413.6K | 56,344(D) | View → |
| Feb 13, 2026 | Feb 13 9:04 PM | Swayze Eric | Proposed Sale | 15,642 | $81.65 | $1.3M | — | View → |
| Feb 11, 2026 | Feb 11 9:02 PM | PARSHALL B LYNNE | Proposed Sale | 10,000 | $82.74 | $827.4K | — | View → |
| Feb 6, 2026 | Feb 10 10:04 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 29,430 | $85.79 | $2.5M | 254,497(D) | View → |
| Feb 6, 2026 | Feb 6 9:09 PM | Monia Brett P | Proposed Sale | 290,203 | $85.55 | $24.8M | — | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Sale | 85,089 | $82.93 | $7.1M | 80,293(D) | View → |
| Jan 30, 2026 | Feb 3 1:52 AM | Eric SwayzeEVP Research | Sale | 6,179 | $82.93 | $512.4K | 47,747(D) | View → |
| Jan 30, 2026 | Feb 3 1:52 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 6,179 | $83.45 | $515.6K | 69,702(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Jul 17 9:13 PM | Peter N ReikesDirector | Grant/Award | 3,399 | — | 3,399(D) | View → |
| Jul 15, 2026 | Jul 17 9:13 PM | Ludwig HantsonDirector | Grant/Award | 3,399 | — | 3,399(D) | View → |
| Jul 15, 2026 | Jul 17 9:12 PM | Joan E HermanDirector | Option Exercise | 5,220 | — | 2,301(D) | View → |
| Jul 15, 2026 | Jul 17 9:12 PM | BERTHELSEN SPENCER RDirector | Option Exercise | 5,220 | — | 2,301(D) | View → |
| Jul 7, 2026 | Jul 9 11:26 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Other (J) | 15,000 | $0.00 | 12,109(D) | View → |
| Jul 7, 2026 | Jul 9 10:07 PM | Allene M. DiazDirector | Option Exercise | 10,111 | $47.11 | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:50 PM | Michael J. YangDirector | Grant/Award | 7,670 | $79.19 | 9,451(D) | View → |
| Jul 1, 2026 | Jul 6 10:50 PM | Joseph LoscalzoDirector | Grant/Award | 7,670 | $79.19 | 7,521(D) | View → |
| Jul 1, 2026 | Jul 6 10:49 PM | Joan E HermanDirector | Grant/Award | 7,670 | $79.19 | 7,521(D) | View → |
| Jul 1, 2026 | Jul 6 10:49 PM | Joseph Klein IIIDirector | Option Exercise | 11,518 | $39.94 | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:49 PM | Joseph Klein IIIDirector | Grant/Award | 7,670 | $79.19 | 16,277(D) | View → |
| Jul 1, 2026 | Jul 6 10:45 PM | Michael R HaydenDirector | Grant/Award | 7,670 | $79.19 | 12,198(D) | View → |
| Jul 1, 2026 | Jul 6 10:44 PM | Allene M. DiazDirector | Grant/Award | 7,670 | $79.19 | 7,521(D) | View → |
| Jul 1, 2026 | Jul 6 10:44 PM | BERTHELSEN SPENCER RDirector | Grant/Award | 7,670 | $79.19 | 7,521(D) | View → |
| Jun 26, 2026 | Jun 30 9:48 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 5,635 | $56.78 | 0(I) | View → |
| Jun 26, 2026 | Jun 30 9:48 PM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 26,000 | $60.89 | 26,000(D) | View → |
| Jun 26, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 50,000 | $56.78 | 99,872(D) | View → |
| Jun 25, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 21,072 | $32.60 | 0(D) | View → |
| Jun 24, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 14,565 | $32.60 | 21,072(D) | View → |
| Jun 12, 2026 | Jun 16 9:26 PM | Holly B. KordasiewiczEVP, Chief Development Officer | Option Exercise | 60,846 | $60.89 | 0(D) | View → |
Page 1 of 4
Next →